» Articles » PMID: 31001655

Respiratory Morbidity, Atopy and Asthma at School Age in Preterm Infants Aged 32-35 weeks

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2019 Apr 20
PMID 31001655
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known about respiratory morbidity and asthma risk in preterm infants (PTIs) with a gestational age (GA) over 32 weeks. This was a prospective study carried out from birth to 7-8 years, comparing two groups: (a) PTIs (GAs 32 weeks + 1 day to 35 weeks + 0 days, without comorbidities) and (b) full-term infants (FTIs; GA ≥ 37 weeks). Risk and protective factors for bronchiolitis and asthma were identified. A total of 232 children (116/group) were included. Sixty-six (56.9%) PTIs and 43 (37.1%) FTIs presented bronchiolitis (p = 0.002). Recurrent wheezing was 52 (44.8%) on PTIs versus 36 (31.0%) on FTIs (p = 0.03). Asthma at school aged was 27 (23.3%) on PTIs and 8 (6.9%) on FTIs (p = 0.020). Asthma risk factors were only detected in group A.Conclusion: PTIs had a higher prevalence of bronchiolitis, recurrent wheezing and asthma; risk factors for asthma are the following: older siblings, allergic father, atopic dermatitis and antibiotic treatment in the first 3 years of life and prematurity itself, which also acted as protective factor for atopic dermatitis. What is known: • In recent decades, there has been a significant increase in the birth of premature babies and consequently, also in the pathologies secondary to the prematurity: a greater number of complications and disorders related to the development and maturation of many organs and systems, especially the respiratory system. Several studies, especially in full-term infants and very preterm infants, have tried to elucidate the risk factors that may influence the development of persistent or chronic respiratory problems such asasthma, but little is known about the aetiology of these disorders in the late or moderate preterm infants. Inthis group of children, the role played by certain factors (early use of antibiotics, chorioamnionitis, smokeexposure, paternal asthma, etc.) on late respiratory morbidity, or asthma, is inconclusive. • Moderate-to-late preterm infants are more predisposed to developing recurrent wheezing/asthma and should adopt control measures. What is new: • Our work provides data related to little-understood aspects of respiratory diseases in this group of late or moderate preterm infants (gestational age between 32 weeks plus 1 day and 35 weeks plus 0 days), by monitoring their evolution from birth to 7-8 years of age, compared with another group of full-term newborns. We aimed to establish the prevalence of bronchiolitis and recurrent wheezing in these children during their first years of life. • The prevalence of school-aged asthma and the risk factors for contracting it were also investigated.

Citing Articles

Respiratory, cardio-metabolic and neurodevelopmental long-term outcomes of moderate to late preterm birth: not just a near term-population. A follow-up study.

Alonso-Lopez P, Arroyas M, Beato M, Ruiz-Gonzalez S, Olabarrieta I, Garcia-Garcia M Front Med (Lausanne). 2024; 11:1381118.

PMID: 39228801 PMC: 11368750. DOI: 10.3389/fmed.2024.1381118.


The Influence of Premature Birth on the Development of Pulmonary Diseases: Focus on the Microbiome.

Wolska M, Wypych T, Rodriguez-Viso P Metabolites. 2024; 14(7).

PMID: 39057705 PMC: 11279213. DOI: 10.3390/metabo14070382.


Lung function in young adulthood in relation to moderate-to-late preterm birth.

Lundberg B, Merid S, Um-Bergstrom P, Wang G, Bergstrom A, Ekstrom S ERJ Open Res. 2024; 10(1).

PMID: 38259815 PMC: 10801715. DOI: 10.1183/23120541.00701-2023.


Interleukin-2 gene methylation levels and interleukin-2 levels associated with environmental exposure as risk biomarkers for preterm birth.

Fucic A, Knezevic J, Krasic J, Polancec D, Sincic N, Sindicic Dessardo N Croat Med J. 2023; 64(5):320-328.

PMID: 37927185 PMC: 10668044.


Are Babies Born Preterm High-Risk Asthma Candidates?.

Caffarelli C, Gracci S, Gianni G, Bernardini R J Clin Med. 2023; 12(16).

PMID: 37629440 PMC: 10455600. DOI: 10.3390/jcm12165400.


References
1.
Mata Fernandez C, Fernandez-Benitez M, Perez Miranda M, Guillen Grima F . Validation of the Spanish version of the Phase III ISAAC questionnaire on asthma. J Investig Allergol Clin Immunol. 2005; 15(3):201-10. View

2.
Asher M, Montefort S, Bjorksten B, Lai C, Strachan D, Weiland S . Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006; 368(9537):733-43. DOI: 10.1016/S0140-6736(06)69283-0. View

3.
Kusel M, de Klerk N, Kebadze T, Vohma V, Holt P, Johnston S . Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007; 119(5):1105-10. PMC: 7125611. DOI: 10.1016/j.jaci.2006.12.669. View

4.
Sardon Prado O, Morera G, Herdman M, Moreno Galdo A, Perez-Yarza E, Detmar S . [Spanish version of the TNO-AZL preschool children quality of life questionnaire (TAPQOL)]. An Pediatr (Barc). 2008; 68(5):420-4. DOI: 10.1157/13120037. View

5.
Paul I, Camera L, Zeiger R, Guilbert T, Bacharier L, Taussig L . Relationship between infant weight gain and later asthma. Pediatr Allergy Immunol. 2009; 21(1 Pt 1):82-9. PMC: 2887600. DOI: 10.1111/j.1399-3038.2009.00926.x. View